QQQ   273.53 (+2.35%)
AAPL   142.45 (+3.08%)
MSFT   240.74 (+3.37%)
META   138.61 (+2.16%)
GOOGL   98.64 (+3.13%)
AMZN   115.88 (+2.55%)
TSLA   242.40 (-8.61%)
NVDA   125.12 (+3.07%)
NIO   15.49 (-1.78%)
BABA   80.45 (+0.58%)
AMD   66.11 (+4.34%)
T   15.90 (+3.65%)
MU   51.72 (+3.23%)
CGC   2.91 (+6.59%)
F   11.47 (+2.41%)
GE   63.60 (+2.73%)
DIS   97.13 (+2.97%)
AMC   6.88 (-1.29%)
PYPL   87.18 (+1.29%)
PFE   44.14 (+0.87%)
NFLX   239.04 (+1.53%)
QQQ   273.53 (+2.35%)
AAPL   142.45 (+3.08%)
MSFT   240.74 (+3.37%)
META   138.61 (+2.16%)
GOOGL   98.64 (+3.13%)
AMZN   115.88 (+2.55%)
TSLA   242.40 (-8.61%)
NVDA   125.12 (+3.07%)
NIO   15.49 (-1.78%)
BABA   80.45 (+0.58%)
AMD   66.11 (+4.34%)
T   15.90 (+3.65%)
MU   51.72 (+3.23%)
CGC   2.91 (+6.59%)
F   11.47 (+2.41%)
GE   63.60 (+2.73%)
DIS   97.13 (+2.97%)
AMC   6.88 (-1.29%)
PYPL   87.18 (+1.29%)
PFE   44.14 (+0.87%)
NFLX   239.04 (+1.53%)
QQQ   273.53 (+2.35%)
AAPL   142.45 (+3.08%)
MSFT   240.74 (+3.37%)
META   138.61 (+2.16%)
GOOGL   98.64 (+3.13%)
AMZN   115.88 (+2.55%)
TSLA   242.40 (-8.61%)
NVDA   125.12 (+3.07%)
NIO   15.49 (-1.78%)
BABA   80.45 (+0.58%)
AMD   66.11 (+4.34%)
T   15.90 (+3.65%)
MU   51.72 (+3.23%)
CGC   2.91 (+6.59%)
F   11.47 (+2.41%)
GE   63.60 (+2.73%)
DIS   97.13 (+2.97%)
AMC   6.88 (-1.29%)
PYPL   87.18 (+1.29%)
PFE   44.14 (+0.87%)
NFLX   239.04 (+1.53%)
QQQ   273.53 (+2.35%)
AAPL   142.45 (+3.08%)
MSFT   240.74 (+3.37%)
META   138.61 (+2.16%)
GOOGL   98.64 (+3.13%)
AMZN   115.88 (+2.55%)
TSLA   242.40 (-8.61%)
NVDA   125.12 (+3.07%)
NIO   15.49 (-1.78%)
BABA   80.45 (+0.58%)
AMD   66.11 (+4.34%)
T   15.90 (+3.65%)
MU   51.72 (+3.23%)
CGC   2.91 (+6.59%)
F   11.47 (+2.41%)
GE   63.60 (+2.73%)
DIS   97.13 (+2.97%)
AMC   6.88 (-1.29%)
PYPL   87.18 (+1.29%)
PFE   44.14 (+0.87%)
NFLX   239.04 (+1.53%)
NASDAQ:SWAV

ShockWave Medical - SWAV Stock Forecast, Price & News

$278.96
+0.89 (+0.32%)
(As of 10/3/2022 12:00 AM ET)
Add
Compare
Today's Range
$270.33
$285.74
50-Day Range
$208.16
$310.53
52-Week Range
$113.36
$314.90
Volume
523,079 shs
Average Volume
531,032 shs
Market Capitalization
$9.98 billion
P/E Ratio
191.07
Dividend Yield
N/A
Price Target
$244.86

ShockWave Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.63 Rating Score
Upside/​Downside
12.2% Downside
$244.86 Price Target
Short Interest
Healthy
4.92% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.55
Upright™ Environmental Score
News Sentiment
0.41mentions of ShockWave Medical in the last 14 days
Based on 9 Articles This Week
Insider Trading
Selling Shares
$30.46 M Sold Last Quarter
Proj. Earnings Growth
33.07%
From $2.57 to $3.42 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.47 out of 5 stars

Medical Sector

229th out of 1,093 stocks

Surgical & Medical Instruments Industry

26th out of 105 stocks

SWAV stock logo

About ShockWave Medical (NASDAQ:SWAV) Stock

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ShockWave Medical and its competitors with MarketBeat's FREE daily newsletter.

SWAV Stock News Headlines

PerkinElmer's (PKI) New Benchtop Platform to Boost Workflows
Stryker's (SYK) OptaBlate Tumor Ablation System Gets FDA Nod
3 Reasons to Retain PacBio (PACB) Stock in Your Portfolio
Shockwave Medical Initiates All-Female Coronary IVL Study
3 Reasons to Hold Catalent (CTLT) Stock in Your Portfolio
Abiomed's (ABMD) Impella-Related Research Gets FDA Clearance
Teleflex (TFX) Witnesses Lower UroLift Sales, Cost Woes
3 Reasons to Hold Insulet (PODD) Stock in Your Portfolio
3 Top Ranked Stocks for Exposure to the Medical Sector
Globus Medical (GMED) Gains Market Share, Cost Woes Stay
Here's Why You Should Hold on to Ecolab (ECL) Stock Now
Here's Why You Should Hold on to BD (BDX) Stock for Now
See More Headlines
Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ShockWave Medical and its competitors with MarketBeat's FREE daily newsletter.

SWAV Company Calendar

Last Earnings
8/08/2022
Today
10/03/2022
Next Earnings (Estimated)
11/14/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SWAV
Fax
N/A
Employees
657
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$244.86
High Stock Price Forecast
$338.00
Low Stock Price Forecast
$165.00
Forecasted Upside/Downside
-12.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.63
Research Coverage
8 Analysts

Profitability

Net Income
$-9,140,000.00
Pretax Margin
15.43%

Debt

Sales & Book Value

Annual Sales
$237.15 million
Book Value
$6.85 per share

Miscellaneous

Free Float
34,396,000
Market Cap
$9.98 billion
Optionable
Not Optionable
Beta
1.08

Key Executives

  • Mr. Douglas E. Godshall M.B.A. (Age 57)
    Pres, CEO & Director
    Comp: $1.4M
  • Mr. Daniel Puckett MBA (Age 58)
    CFO, Principal Financial Officer & Sec.
    Comp: $658.71k
  • Mr. Isaac  ZachariasMr. Isaac Zacharias (Age 47)
    Chief Commercial Officer
    Comp: $679.54k
  • Mr. Daniel Hawkins (Age 55)
    Founder and Sr. Advisor
  • Mr. John M. Adams (Age 75)
    Co-Founder and Technical Advisor
  • Mr. Mike Maszy
    VP of Operations
  • Ms. Trinh  PhungMs. Trinh Phung (Age 44)
    Chief Accounting Officer, Principal Accounting Officer & VP of Fin.
  • Ms. Debbie Kaster
    VP of Investor Relations
  • Mr. Hajime Tada J.D.
    Gen. Counsel & Sec.
  • Mr. Rob Williamson Jr.
    VP of Sales













SWAV Stock - Frequently Asked Questions

Should I buy or sell ShockWave Medical stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ShockWave Medical in the last twelve months. There are currently 1 sell rating, 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SWAV shares.
View SWAV analyst ratings
or view top-rated stocks.

What is ShockWave Medical's stock price forecast for 2022?

8 brokerages have issued 1 year price targets for ShockWave Medical's stock. Their SWAV share price forecasts range from $165.00 to $338.00. On average, they anticipate the company's stock price to reach $244.86 in the next year. This suggests that the stock has a possible downside of 12.1%.
View analysts price targets for SWAV
or view top-rated stocks among Wall Street analysts.

How have SWAV shares performed in 2022?

ShockWave Medical's stock was trading at $178.33 on January 1st, 2022. Since then, SWAV shares have increased by 56.3% and is now trading at $278.65.
View the best growth stocks for 2022 here
.

When is ShockWave Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 14th 2022.
View our SWAV earnings forecast
.

How were ShockWave Medical's earnings last quarter?

ShockWave Medical, Inc. (NASDAQ:SWAV) announced its earnings results on Monday, August, 8th. The company reported $0.68 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.25. The company had revenue of $120.70 million for the quarter, compared to analyst estimates of $107.51 million. ShockWave Medical had a trailing twelve-month return on equity of 21.25% and a net margin of 15.11%. The company's revenue for the quarter was up 115.5% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.01) earnings per share.

What guidance has ShockWave Medical issued on next quarter's earnings?

ShockWave Medical issued an update on its FY 2022 earnings guidance on Tuesday, September, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $465.00 million-$475.00 million, compared to the consensus revenue estimate of $448.64 million.

What is Doug Godshall's approval rating as ShockWave Medical's CEO?

8 employees have rated ShockWave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees.

What other stocks do shareholders of ShockWave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ShockWave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA).

When did ShockWave Medical IPO?

(SWAV) raised $75 million in an initial public offering (IPO) on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

What is ShockWave Medical's stock symbol?

ShockWave Medical trades on the NASDAQ under the ticker symbol "SWAV."

How do I buy shares of ShockWave Medical?

Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ShockWave Medical's stock price today?

One share of SWAV stock can currently be purchased for approximately $278.65.

How much money does ShockWave Medical make?

ShockWave Medical (NASDAQ:SWAV) has a market capitalization of $9.97 billion and generates $237.15 million in revenue each year. The company earns $-9,140,000.00 in net income (profit) each year or $1.46 on an earnings per share basis.

How many employees does ShockWave Medical have?

The company employs 657 workers across the globe.

How can I contact ShockWave Medical?

ShockWave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The official website for the company is www.shockwavemedical.com. The company can be reached via phone at (510) 279-4262 or via email at investors@shockwavemedical.com.

This page (NASDAQ:SWAV) was last updated on 10/3/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.